DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of "Hold" by Brokerages

DaVita Inc. (NYSE:DVA - Get Free Report) has been given an average recommendation of "Hold" by the five research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $161.80.

DVA has been the subject of several recent analyst reports. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a report on Monday, October 7th.

Institutional Investors Weigh In On DaVita

Several large investors have recently bought and sold shares of DVA. Transcendent Capital Group LLC purchased a new stake in shares of DaVita in the 3rd quarter valued at approximately $25,000. Blue Trust Inc. raised its stake in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. purchased a new stake in DaVita during the 2nd quarter worth about $43,000. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth about $60,000. Finally, Point72 Hong Kong Ltd purchased a new position in shares of DaVita in the 2nd quarter valued at about $68,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Stock Up 2.9 %

Shares of DVA opened at $151.85 on Friday. The stock has a 50 day moving average price of $157.18 and a 200 day moving average price of $150.83. DaVita has a one year low of $103.40 and a one year high of $169.51. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The stock has a market capitalization of $12.45 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 0.86 and a beta of 0.90.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). The business had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business's revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.85 earnings per share. Equities research analysts forecast that DaVita will post 9.71 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.